In AML and other cancer cells, FLT3-ITD inhibits Foxo3a[77,78], leading to Myc activation and glutaminolysis stimulation, which, in turn, generates anaplerotic substrates that fuel the TCA cycle, increasing citrate synthesis and its transport to cytoplasm. Here, MYC is linked to acute myeloid leukemia.